USD 0.63
(-11.99%)
Year | Gross Profit | Gross Profit Growth |
---|---|---|
2023 | 9.07 Million USD | 56.07% |
2022 | 6.21 Million USD | -7.93% |
2021 | 6.74 Million USD | 33.12% |
2020 | 5.07 Million USD | -25.04% |
2019 | 6.76 Million USD | 56.97% |
2018 | 4.3 Million USD | 108.26% |
2017 | 2.06 Million USD | -29.79% |
2016 | 2.94 Million USD | 149.96% |
2015 | 1.17 Million USD | -24.37% |
2014 | 1.55 Million USD | 165.59% |
2013 | 587 Thousand USD | 58.65% |
2012 | 370 Thousand USD | 0.0% |
Year | Gross Profit | Gross Profit Growth |
---|---|---|
2024 Q2 | 2.63 Million USD | 35.16% |
2024 Q3 | 2.2 Million USD | -16.23% |
2024 Q1 | 1.95 Million USD | -17.64% |
2023 Q3 | 2.45 Million USD | 8.96% |
2023 Q4 | 2.36 Million USD | -3.54% |
2023 FY | 9.69 Million USD | 56.07% |
2023 Q1 | 2 Million USD | 19.19% |
2023 Q2 | 2.25 Million USD | 12.7% |
2022 Q4 | 1.67 Million USD | -0.47% |
2022 FY | 6.21 Million USD | -7.93% |
2022 Q1 | 1.2 Million USD | -49.94% |
2022 Q3 | 1.68 Million USD | 2.74% |
2022 Q2 | 1.64 Million USD | 35.73% |
2021 Q4 | 2.41 Million USD | 33.65% |
2021 Q3 | 1.8 Million USD | 39.86% |
2021 Q2 | 1.29 Million USD | 4.62% |
2021 Q1 | 1.23 Million USD | -9.26% |
2021 FY | 6.74 Million USD | 33.12% |
2020 Q2 | 1.25 Million USD | 97.65% |
2020 Q4 | 1.36 Million USD | -24.93% |
2020 Q3 | 1.81 Million USD | 44.0% |
2020 FY | 5.07 Million USD | -25.04% |
2020 Q1 | 637 Thousand USD | -65.64% |
2019 Q3 | 1.75 Million USD | 12.18% |
2019 Q1 | 1.59 Million USD | 7.24% |
2019 Q2 | 1.56 Million USD | -2.44% |
2019 Q4 | 1.85 Million USD | 5.94% |
2019 FY | 6.76 Million USD | 56.97% |
2018 Q2 | 967 Thousand USD | 26.08% |
2018 FY | 4.3 Million USD | 108.26% |
2018 Q4 | 1.49 Million USD | 37.67% |
2018 Q3 | 1.08 Million USD | 12.0% |
2018 Q1 | 767 Thousand USD | -1.29% |
2017 Q3 | 544 Thousand USD | 37.37% |
2017 Q4 | 777 Thousand USD | 42.83% |
2017 FY | 2.06 Million USD | -29.79% |
2017 Q1 | 352 Thousand USD | -58.24% |
2017 Q2 | 396 Thousand USD | 12.5% |
2016 Q2 | 203 Thousand USD | -86.45% |
2016 FY | 2.94 Million USD | 149.96% |
2016 Q4 | 843 Thousand USD | 109.18% |
2016 Q3 | 403 Thousand USD | 98.52% |
2016 Q1 | 1.49 Million USD | 872.16% |
2015 Q1 | 403 Thousand USD | -27.26% |
2015 FY | 1.17 Million USD | -24.37% |
2015 Q4 | -194 Thousand USD | -141.45% |
2015 Q3 | 468 Thousand USD | -6.77% |
2015 Q2 | 502 Thousand USD | 24.57% |
2014 Q3 | 479.78 Thousand USD | 952.52% |
2014 Q2 | 45.58 Thousand USD | -90.49% |
2014 Q1 | 479.48 Thousand USD | 459.98% |
2014 FY | 1.55 Million USD | 165.59% |
2014 Q4 | 554 Thousand USD | 15.47% |
2013 FY | 587 Thousand USD | 58.65% |
2013 Q4 | -133.19 Thousand USD | -144.29% |
2013 Q1 | 116.47 Thousand USD | -61.26% |
2013 Q2 | 303 Thousand USD | 160.15% |
2013 Q3 | 300.72 Thousand USD | -0.75% |
2012 Q3 | - USD | 0.0% |
2012 FY | 370 Thousand USD | 0.0% |
2012 Q2 | - USD | 0.0% |
2012 Q4 | 300.66 Thousand USD | 0.0% |
Name | Gross Profit | Gross Profit Difference |
---|---|---|
Akoya Biosciences, Inc. | 56.3 Million USD | 83.875% |
AngioDynamics, Inc. | 154.69 Million USD | 94.131% |
AtriCure, Inc. | 300.37 Million USD | 96.977% |
Avinger, Inc. | 2 Million USD | -353.27% |
Azenta, Inc. | 263.14 Million USD | 96.55% |
BioLife Solutions, Inc. | 46.75 Million USD | 80.581% |
The Cooper Companies, Inc. | 2.35 Billion USD | 99.615% |
Daxor Corporation | 1.1 Million USD | -722.791% |
Femasys Inc. | 691.9 Thousand USD | -1212.182% |
GlucoTrack, Inc. | -13 Thousand USD | 69938.462% |
Harvard Bioscience, Inc. | 60.86 Million USD | 85.084% |
Hologic, Inc. | 2.22 Billion USD | 99.592% |
ICU Medical, Inc. | 739.87 Million USD | 98.773% |
Intuitive Surgical, Inc. | 4.72 Billion USD | 99.808% |
KORU Medical Systems, Inc. | 16.7 Million USD | 45.662% |
LeMaitre Vascular, Inc. | 127.04 Million USD | 92.854% |
Innovative Eyewear, Inc. | -119.32 Thousand USD | 7708.377% |
Innovative Eyewear, Inc. | -119.32 Thousand USD | 7708.377% |
Masimo Corporation | 1 Billion USD | 99.095% |
Microbot Medical Inc. | -106 Thousand USD | 8665.094% |
Meihua International Medical Technologies Co., Ltd. | 33.09 Million USD | 72.567% |
Merit Medical Systems, Inc. | 583.87 Million USD | 98.445% |
Nephros, Inc. | 8.4 Million USD | -8.019% |
NovoCure Limited | 381.05 Million USD | 97.617% |
NEXGEL, Inc. | 619 Thousand USD | -1366.721% |
NEXGEL, Inc. | 619 Thousand USD | -1366.721% |
Singular Genomics Systems, Inc. | -558 Thousand USD | 1727.061% |
OraSure Technologies, Inc. | 179.42 Million USD | 94.94% |
Pro-Dex, Inc. | 14.55 Million USD | 37.606% |
Pulse Biosciences, Inc. | -1.2 Million USD | 852.196% |
Predictive Oncology Inc. | 1.14 Million USD | -692.72% |
Precision Optics Corporation, Inc. | 5.79 Million USD | -56.595% |
QuidelOrtho Corporation | 1.49 Billion USD | 99.392% |
Repligen Corporation | 315.22 Million USD | 97.12% |
Sanara MedTech Inc. | 57.13 Million USD | 84.11% |
STAAR Surgical Company | 252.65 Million USD | 96.407% |
Sharps Technology, Inc. | -891.24 Thousand USD | 1118.684% |
Utah Medical Products, Inc. | 30.03 Million USD | 69.775% |
DENTSPLY SIRONA Inc. | 2.08 Billion USD | 99.565% |
Jin Medical International Ltd. | 6.78 Million USD | -33.813% |